PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1980183
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1980183
The global ophthalmic devices market was valued at USD 31.45 billion in 2025 and is projected to grow to USD 32.9 billion in 2026, reaching USD 48.44 billion by 2034, representing a CAGR of 5% during the forecast period. North America dominated the market in 2025 with a 40.92% share, driven by the widespread adoption of advanced intraocular lenses (IOLs), high volumes of ophthalmic surgeries, and a strong presence of major market players.
The market encompasses ophthalmic diagnostics and surgical devices, as well as vision care products such as contact lenses and ocular health devices. Increasing prevalence of vision disorders, including myopia, high myopia, cataracts, glaucoma, diabetic retinopathy, and age-related macular degeneration, is driving demand globally. According to the World Health Organization (WHO) and Brien Holden Vision Institute, by 2050, approximately 52% of the global population is expected to be affected by myopia and 10% by high myopia, highlighting the growing need for ophthalmic devices.
Market Drivers
The increasing prevalence of vision disorders, along with the rise in eye surgeries, is the primary driver for market growth. For instance, in the U.S., approximately 3.9 million cataract surgeries were performed in 2018, reflecting the growing demand for surgical devices. Additionally, technological advancements, such as the development of micro-invasive glaucoma (MIGs) surgical implants and trifocal intraocular lenses, have further propelled market growth.
Other drivers include favorable reimbursement policies, rising per capita healthcare expenditure, and increasing patient awareness of eye health. Vision care devices, particularly contact lenses, have seen higher adoption rates, with an estimated 45 million people in the U.S. using contact lenses, contributing significantly to the vision care segment.
Market Restraints
The high cost of ophthalmic devices limits growth in emerging countries. For example, femtosecond lasers cost between USD 200,000 and USD 400,000, making them less accessible to small and mid-sized clinics. Additionally, low treatment rates in emerging nations due to limited healthcare infrastructure, product accessibility, and patient awareness continue to restrain market expansion.
Impact of COVID-19
The COVID-19 pandemic negatively impacted the market, particularly the surgical segment, as ophthalmic procedures declined significantly. An analysis of 228 hospitals in the U.S. showed an 81% reduction in ophthalmology patient visits during March-April 2020, with cataract surgeries declining by 97%. Conversely, vision care devices such as eye-drops saw increased demand due to panic-buying and stockpiling amid lockdowns.
By Product:
By End User:
Key Players and Industry Developments
Leading companies include Alcon, Johnson & Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec, Cooper Companies, Inc., Essilor, Hoya Corporation, and NIDEK CO., LTD. These players are focused on R&D, product innovation, and geographical expansion to strengthen their market positions.
Recent developments include:
Conclusion
The ophthalmic devices market is projected to grow from USD 31.45 billion in 2025 to USD 48.44 billion by 2034 at a CAGR of 5%, driven by rising prevalence of vision disorders, growing adoption of advanced devices, and increasing ophthalmic surgeries. While high device costs and low treatment rates in emerging nations remain challenges, technological advancements, innovative product launches, and expanding vision care awareness are expected to sustain market growth across all regions.
Segmentation By Product Type
By End-user
By Geography